PLATINUM SENSITIVE OVARIAN CANCER (PSOC)

Clinical trials for PLATINUM SENSITIVE OVARIAN CANCER (PSOC) explained in plain language.

Never miss a new study

Get alerted when new PLATINUM SENSITIVE OVARIAN CANCER (PSOC) trials appear

Sign up with your email to follow new studies for PLATINUM SENSITIVE OVARIAN CANCER (PSOC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New targeted drug trial offers hope for Tough-to-Treat cancers

Disease control Recruiting now

This study is testing a new drug called Rina-S in people whose solid tumor cancers have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug can shrink tumors. It is for people with several types of advanced cancer, including ovarian,…

Matched conditions: PLATINUM SENSITIVE OVARIAN CANCER (PSOC)

Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control

Last updated Mar 12, 2026 13:51 UTC

PLATINUM SENSITIVE OVARIAN CANCER (PSOC)

Get alerted when new PLATINUM SENSITIVE OVARIAN CANCER (PSOC) trials appear

New targeted drug trial offers hope for Tough-to-Treat cancers